Researchers and entrepreneurs from the University of Toronto are set to showcase their innovative work to a global audience during Elevate 2019, Canada’s largest technology and innovation festival.
The week-long event, which kicks off Friday, features hundreds of speakers and is expected to draw tens of thousands of attendees. U of T will play a central role thanks to its contributions to Toronto’s thriving technology ecosystem and research that underpins key advances in fields like artificial intelligence (AI) and precision medicine.
At this year’s festival, U of T experts will be featured prominently at Elevate AI, a day-long program on Sept. 25 devoted to conversations around AI research, applications and commercialization held at the MaRS Discovery District.
The scheduled speakers include Brendan Frey, the founder and CEO of Deep Genomics, which is using AI to build life-saving genetic therapies.
“Lots of companies talk about using AI to disrupt drug discovery, but nobody has made it work yet,” says Frey, a professor in U of T’s Faculty of Applied Science & Engineering with cross appointments in the department of computer science and the Donnelly Centre for Cellular and Biomolecular Research.
“The elephant in the room – whether you’re talking to pharmaceutical companies that are trying to advance drugs or patients who are looking for drugs – is: Will AI actually make a difference in drug discovery and medicine?”